"
Team:Evry/Notebook/CellCharacterization/Antibiotic test/08-22-2014
From 2014.igem.org
(Difference between revisions)
| Line 7: | Line 7: | ||
<p align="justify"> | <p align="justify"> | ||
| - | <u>Antibiotics' tests on MB 1X plates - Results Day2</u> <br> | + | <u><big><FONT COLOR=#003333>Antibiotics' tests on MB 1X plates - Results Day2</font></big></u> <br> |
Results of antibiotics' tests on plate are calculated as percentage of bacteria's growth by compared with the controle case. | Results of antibiotics' tests on plate are calculated as percentage of bacteria's growth by compared with the controle case. | ||
Pseudovibrio coming from culture with antibiotics (part B on plates), are taken from antibiotics' range in M9 at Day2.<br> | Pseudovibrio coming from culture with antibiotics (part B on plates), are taken from antibiotics' range in M9 at Day2.<br> | ||
| Line 25: | Line 25: | ||
<img src="https://static.igem.org/mediawiki/2014/e/e8/Erm_MB_J1_Graphe.jpg" alt="Erm" /> | <img src="https://static.igem.org/mediawiki/2014/e/e8/Erm_MB_J1_Graphe.jpg" alt="Erm" /> | ||
| - | + | <div align="center"> <img src="https://static.igem.org/mediawiki/2014/0/09/Graphe_J2-MB1X.jpg" alt="Graphs" style="width:80%; height:80%" /></div> | |
<br> | <br> | ||
| - | + | <div align="center"> <img src="https://static.igem.org/mediawiki/2014/2/23/PhotoJ2MB1X.jpg" alt="photo" style="width:80%; height:80%"/></div> | |
<br> | <br> | ||
| Line 49: | Line 49: | ||
<img src="https://static.igem.org/mediawiki/2014/d/d2/Erythromycine_MB05_J2.jpg" alt="Erm" /> | <img src="https://static.igem.org/mediawiki/2014/d/d2/Erythromycine_MB05_J2.jpg" alt="Erm" /> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/5/5b/Graphe_J2-MB05X%282%29.jpg" alt="Graphs" /> | + | <div align="center"> <img src="https://static.igem.org/mediawiki/2014/5/5b/Graphe_J2-MB05X%282%29.jpg" alt="Graphs" style="width:80%; height:80%" /></div> |
<br> | <br> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/6/63/PhotoJ2MB05X.jpg" alt="photo" /> | + | <div align="center"> <img src="https://static.igem.org/mediawiki/2014/6/63/PhotoJ2MB05X.jpg" alt="photo" style="width:80%; height:80%" /></div> |
<br> | <br> | ||
| Line 73: | Line 73: | ||
<img src="https://static.igem.org/mediawiki/2014/4/43/Erythromycine_M9s_J2.jpg" alt="Erm" /> | <img src="https://static.igem.org/mediawiki/2014/4/43/Erythromycine_M9s_J2.jpg" alt="Erm" /> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/8/87/Graphe_J2-M91X.jpg" alt="Graphs" /> | + | <div align="center"> <img src="https://static.igem.org/mediawiki/2014/8/87/Graphe_J2-M91X.jpg" alt="Graphs" style="width:80%; height:80% /> </div> |
<u>Differed launch of antibiotics' tests</u> <br> | <u>Differed launch of antibiotics' tests</u> <br> | ||
Revision as of 16:34, 12 October 2014
Antibiotics' tests on MB 1X plates - Results Day2
Results of antibiotics' tests on plate are calculated as percentage of bacteria's growth by compared with the controle case.
Pseudovibrio coming from culture with antibiotics (part B on plates), are taken from antibiotics' range in M9 at Day2.
Antibiotics' tests on MB 0.5X plates - Results Day2
Results of antibiotics' tests on plate are calculated as percentage of bacteria's growth by compared with the controle case. Pseudovibrio coming from culture with antibiotics (part B on plates), are taken from antibiotics' range in M9 at Day2.
Antibiotics' tests on M9 1X plates - Results Day2
Results of antibiotics' tests on plate are calculated as percentage of bacteria's growth by compared with the controle case. Pseudovibrio coming from culture with antibiotics (part B on plates), are taken from antibiotics' range in M9 at Day2.
Aug 22
